全文获取类型
收费全文 | 6246篇 |
免费 | 482篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 82篇 |
儿科学 | 148篇 |
妇产科学 | 106篇 |
基础医学 | 994篇 |
口腔科学 | 148篇 |
临床医学 | 630篇 |
内科学 | 1246篇 |
皮肤病学 | 255篇 |
神经病学 | 714篇 |
特种医学 | 238篇 |
外科学 | 734篇 |
综合类 | 30篇 |
一般理论 | 6篇 |
预防医学 | 469篇 |
眼科学 | 81篇 |
药学 | 449篇 |
中国医学 | 8篇 |
肿瘤学 | 415篇 |
出版年
2023年 | 60篇 |
2022年 | 48篇 |
2021年 | 176篇 |
2020年 | 155篇 |
2019年 | 189篇 |
2018年 | 232篇 |
2017年 | 184篇 |
2016年 | 209篇 |
2015年 | 230篇 |
2014年 | 246篇 |
2013年 | 354篇 |
2012年 | 497篇 |
2011年 | 477篇 |
2010年 | 300篇 |
2009年 | 259篇 |
2008年 | 387篇 |
2007年 | 349篇 |
2006年 | 340篇 |
2005年 | 285篇 |
2004年 | 238篇 |
2003年 | 228篇 |
2002年 | 174篇 |
2001年 | 73篇 |
2000年 | 61篇 |
1999年 | 82篇 |
1998年 | 58篇 |
1997年 | 35篇 |
1996年 | 34篇 |
1995年 | 30篇 |
1994年 | 18篇 |
1993年 | 23篇 |
1992年 | 45篇 |
1991年 | 40篇 |
1990年 | 39篇 |
1989年 | 40篇 |
1988年 | 51篇 |
1987年 | 35篇 |
1986年 | 33篇 |
1985年 | 25篇 |
1984年 | 28篇 |
1983年 | 31篇 |
1982年 | 21篇 |
1981年 | 19篇 |
1979年 | 22篇 |
1978年 | 19篇 |
1976年 | 18篇 |
1971年 | 17篇 |
1970年 | 19篇 |
1969年 | 16篇 |
1967年 | 17篇 |
排序方式: 共有6753条查询结果,搜索用时 31 毫秒
1.
2.
Florian Huemer Thomas Melchardt Bettina Jansko Adam Wahida Stefanie Jilg Philipp J. Jost Eckhard Klieser Katja Steiger Teresa Magnes Lisa Pleyer Sigrun Greil‐Ressler Christof Rass Richard Greil Alexander Egle 《European journal of haematology》2019,102(5):437-441
Acute myeloid leukemia (AML) is a disease of the elderly population and survival remains poor after failure of hypomethylating agents (HMA). The BCL‐2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or HMA in AML. In this case series, patients with secondary AML (sAML) not eligible for intensive chemotherapy and refractory to HMA were treated with venetoclax within a named patient program at our tertiary cancer center in Salzburg, Austria. Between April 2017 and September 2018, seven patients with sAML received venetoclax therapy. Two out of seven patients achieved a complete remission upon venetoclax initiation with a PFS of 505 days and 352 days and another patient achieved complete peripheral blood blast clearing within nine days after start of venetoclax. Among the venetoclax responders, primary refractory disease to prior HMA therapy was documented, 2 patients harbored IDH1/IDH2 mutations and one patient had an antecedent myeloproliferative neoplasm. High BCL‐2 and/or BIM expression in myeloblasts was found in venetoclax responders and response was significantly associated with overall survival (responders: 364 days versus non‐responders: 24 days, P = 0.018). Venetoclax monotherapy is safe and is able to induce durable responses in elderly patients with secondary AML after treatment failure with HMA. 相似文献
3.
4.
5.
Hönikl Lisa Stefanie Lämmer Friederike Gempt Jens Meyer Bernhard Schlegel Jürgen Delbridge Claire 《Journal of neuro-oncology》2020,147(3):567-575
Journal of Neuro-Oncology - Glioblastoma multiforme (GBM) is a highly malignant glial tumor, affecting men more often than women. The reason for this gender-specific predominance remains unclear,... 相似文献
6.
Stefanie Hassel Gulshan B. Sharma Gsine L. Alders Andrew D. Davis Stephen R. Arnott Benicio N. Frey Geoffrey B. Hall Jacqueline K. Harris Raymond W. Lam Roumen Milev Daniel J. Müller Susan Rotzinger Mojdeh Zamyadi Sidney H. Kennedy Stephen C. Strother Glenda M. MacQueen 《Human brain mapping》2020,41(6):1400-1415
Task‐based functional neuroimaging methods are increasingly being used to identify biomarkers of treatment response in psychiatric disorders. To facilitate meaningful interpretation of neural correlates of tasks and their potential changes with treatment over time, understanding the reliability of the blood‐oxygen‐level dependent (BOLD) signal of such tasks is essential. We assessed test–retest reliability of an emotional conflict task in healthy participants collected as part of the Canadian Biomarker Integration Network in Depression. Data for 36 participants, scanned at three time points (weeks 0, 2, and 8) were analyzed, and intra‐class correlation coefficients (ICC) were used to quantify reliability. We observed moderate reliability (median ICC values between 0.5 and 0.6), within occipital, parietal, and temporal regions, specifically for conditions of lower cognitive complexity, that is, face, congruent or incongruent trials. For these conditions, activation was also observed within frontal and sub‐cortical regions, however, their reliability was poor (median ICC < 0.2). Clinically relevant prognostic markers based on task‐based fMRI require high predictive accuracy at an individual level. For this to be achieved, reliability of BOLD responses needs to be high. We have shown that reliability of the BOLD response to an emotional conflict task in healthy individuals is moderate. Implications of these findings to further inform studies of treatment effects and biomarker discovery are discussed. 相似文献
7.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献
8.
9.
Theresa M. Thole Joern Toedling Annika Sprüssel Sebastian Pfeil Larissa Savelyeva David Capper Clemens Messerschmidt Dieter Beule Stefanie Groeneveld-Krentz Cornelia Eckert Guido Gambara Anton G. Henssen Sabine Finkler Johannes H. Schulte Anja Sieber Nils Bluethgen Christian R. A. Regenbrecht Annette Künkele Marco Lodrini Angelika Eggert Hedwig E. Deubzer 《International journal of cancer. Journal international du cancer》2020,146(4):1031-1041
Accurate modeling of intratumor heterogeneity presents a bottleneck against drug testing. Flexibility in a preclinical platform is also desirable to support assessment of different endpoints. We established the model system, OHC-NB1, from a bone marrow metastasis from a patient diagnosed with MYCN-amplified neuroblastoma and performed whole-exome sequencing on the source metastasis and the different models and passages during model development (monolayer cell line, 3D spheroid culture and subcutaneous xenograft tumors propagated in mice). OHC-NB1 harbors a MYCN amplification in double minutes, 1p deletion, 17q gain and diploid karyotype, which persisted in all models. A total of 80–540 single-nucleotide variants (SNVs) was detected in each sample, and comparisons between the source metastasis and models identified 34 of 80 somatic SNVs to be propagated in the models. Clonal reconstruction using the combined copy number and SNV data revealed marked clonal heterogeneity in the originating metastasis, with four clones being reflected in the model systems. The set of OHC-NB1 models represents 43% of somatic SNVs and 23% of the cellularity in the originating metastasis with varying clonal compositions, indicating that heterogeneity is partially preserved in our model system. 相似文献
10.
Schmitz Jan Jansen Stefanie Meyer Moritz Hinkelbein Jochen 《Notfall & Rettungsmedizin》2022,25(4):285-293
Notfall + Rettungsmedizin - Tauchunfälle sind vergleichsweise selten und stellen (Erst‑)Helfer vor besondere Herausforderungen. Sie müssen schnell und kompetent behandelt werden, da... 相似文献